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Lewis rats show increased anxiety-like behaviors and drug consumption compared with Sprague-Dawley rats. Prior work suggests
norepinephrine (NE) signaling in the bed nucleus of the stria terminalis (BNST) could have a role in mediating these phenotypes. Here,
we investigated NE content and dynamics in the ventral BNST (vBNST) using fast-scan cyclic voltammetry in these two rat strains. We
found that NE release evoked by electrical stimulus and its subsequent uptake was dysregulated in the more anxious Lewis rats. Because
addiction is a multifaceted disease influenced by both genetic and environmental factors, we hypothesized NE dynamics would vary in
these strains after the induction of a physical dependence on morphine. Following naloxone-precipitated morphine withdrawal, NE
release and uptake dynamics were not changed in Lewis rats but were significantly altered in Sprague-Dawley rats. The alterations in
Sprague-Dawley rats were accompanied by an increase in anxiety-like behavior in those animals as measured with the elevated plus
maze. These studies suggest novel mechanisms involved in the development of affective disorders, and highlight the noradrenergic system
in the vBNST as a common substrate for the manifestation of pathological anxiety and addiction.
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In drug-dependent individuals, researchers have highlighted
the development of a persistent ‘negative emotional state’
when access to drugs is terminated (Koob, 2009). Substance
abuse is often co-morbid with anxiety disorders and
impacted by stressful life experiences (Hyman et al, 2009;
Sinha, 2008). The risk for developing an addiction, however,
varies considerably between individuals, and different
people can have very different responses to drug or stress
exposure. One means for addressing this issue is examining
animals with divergent behavioral phenotypes in appro-
priate neuronal structures. Akin to human addicts, inbred
Lewis (L) rats self-administer opiates at high levels (George
and Goldberg, 1989), and show escalation of drug-taking
behavior (Picetti et al, 2012). Additionally, L rats display
several anxiety-like phenotypes as compared with outbred
Sprague-Dawley (SD) rats, as well as hypocortisolemia; thus,
they have been suggested to be a good model of post-
traumatic stress disorder (PTSD) (Cohen et al, 2006).
The bed nucleus of the stria terminalis (BNST) is a
forebrain nucleus in the extended amygdala positioned to
relay between cortical, hippocampal and amygdalar inputs,
and stress and reward centers (Drolet, 2009). The BNST is
densely innervated by noradrenergic fibers arising from the
A1, A2 (via the ventral noradrenergic bundle or VNAB), and
A6 (via the dorsal noradrenergic bundle) cell bodies (Forray
and Gysling, 2004). NE signaling within the BNST
modulates anxiety-like behavior and influences induction
of the hypothalamic–pituitary–adrenal (HPA) axis (Cecchi
et al, 2002), affects expression of learned and physical
opiate withdrawal behaviors (Delfs et al, 2000) and
contributes to stress-induced reinstatement of drug seeking
(Erb et al, 2000; Leri et al, 2002; Wang et al, 2001).
Furthermore, NE impacts both excitatory (McElligott and
Winder, 2009) and inhibitory synaptic transmission
(Dumont and Williams, 2004), induces synaptic plasticity
(McElligott and Winder, 2008), and releases corticotropin-
releasing factor (CRF) in the BNST (McElligott et al, 2010;
Nobis et al, 2011). The Morilak lab found that extracellular
NE in the BNST was the same in non-manipulated L and SD
rats; however, when restrained for 30 min, extracellular NE
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was elevated in L rats compared with SD rats (Pardon
et al, 2002). Furthermore, L rats exhibit fear generalization
and anxiety-like behaviors that are BNST dependent
(Duvarci et al, 2009).
Here, we hypothesized that the noradrenergic system
projecting to the BNST may be differently regulated in these
two rat strains. Furthermore, we tested whether the
noradrenergic system is differentially modulated in a model
of morphine addiction. Previously, we demonstrated that
NE dynamics and their regulation can be examined in the
BNST with fast-scan cyclic voltammetry (Herr et al, 2012;
Park et al, 2009). We used this technique in the ventral
BNST (vBNST) to investigate the mechanisms underlying
differences in NE overflow in L rats as compared with SD
rats, and to test the hypothesis that morphine dependence
alters regulatory mechanisms at noradrenergic neurons. We
found that non-manipulated L rats had a reduced rate of
clearance and decreased sensitivity at their a2-adrenergic
receptors (ARs) as compared with SD rats. Furthermore,
using high-performance liquid chromatography (HPLC), we
found that non-manipulated L rats had higher NE tissue
content. When SD rats were made physically dependent on
morphine (Schulteis et al, 1999), modeling the condition of
a human addict, there was a significant reduction in their
NE uptake rate and in their response to a challenge with an
a2-AR antagonist as compared with controls. In contrast,
neither clearance rate nor a2-AR sensitivity were different in
morphine-dependent L rats as compared with control or
non-manipulated animals. Correlated to these alterations at
NE synapses in the BNST, morphine-dependent SD rats, but
not L rats, showed heightened anxiety-like behavior as
compared with controls. The changes that occurred in
morphine-dependent SD rats were profound: they exhibited
indistinguishable NE uptake rates and similar responses to
an a2-AR antagonist as non-manipulated L rats. Thus,
noradrenergic synapses underwent a remarkable adaptation
when SD rats were made physically dependent on
morphine. Furthermore, the data revealed that the vBNST




All experiments were performed in accordance with the
University of North Carolina at Chapel Hill (UNC)
Institutional Animal Care and Use Committee’s guidelines.
SD and L rats (males; 350–450 g; L rats total n¼ 70, SD total
n¼ 85; Charles River, Wilmington, MA) were housed within
UNC animal facilities and given food and water ad libitum.
Electrochemical, biochemical, and behavioral experiments
were performed as follows: voltammetry, SD n¼ 34,
L n¼ 26; HPLC, SD n¼ 22, L n¼ 15; autoradiography,
SD n¼ 14, L n¼ 13; elevated plus maze, SD n¼ 15, L n¼ 16.
Evoked NE Release
NE release in the vBNST was evoked from stimulation of
the VNAB as previously described (Park et al, 2009)
(Supplementary Methods).
Determination of NE and Dopamine Content in Tissue
Slices
Brains were rapidly removed from anesthetized rats
(urethane 1.5 mg/kg). Coronal sections (300 mm thick) were
prepared using a Lancer Vibratome (World Precision
Instruments, Sarasota, FL) in 4 1C artificial cerebral spinal
fluid (aCSF). The aCSF (in mM: 126 NaCl, 25 NaHCO3, 2.45
KCl, 12 NaH2PO4, 1.2 MgCl2, 2.4 CaCl2, 20 HEPES, and
11 glucose) was adjusted to pH 7.4 and oxygenated
(95% O2/5% CO2). Tissue containing the vBNST or nucleus
accumbens (NAc) was excised with a 1-mm punch, and homo-
genized in 0.1 N HClO4 containing 1mM hydroquinone. Tissue
processing and HPLC were performed as previously described
(Park et al, 2009) (Supplementary Methods).
Acute Morphine Dependence
The morphine-dependence protocol was modified from
Schulteis et al, 1999 (Supplementary Methods). Briefly, over
the course of 3 days rats were injected once daily with
10 mg/kg morphine s.c., followed 4 h later by 1 mg/kg
naloxone s.c. Behavioral, electrochemical, and autoradio-
graphy experiments were performed on the fourth day.
Elevated Plus Maze
The elevated plus maze (EPM) was used to assay anxiety-
like behavior. Animals were isolated in a novel cage for
5 min before running the maze. Animals explored the maze
for 5 min and their movement and time spent in
each section (open arms, center, enclosed arms) was
measured and recorded using Ethovision software (Noldus,
Netherlands).
Chemicals and Drugs
All chemicals and drugs were purchased from Sigma-
Aldrich (St Louis, MO), with the exception of naloxone
(Tocris Bioscience, Ellisville, MO), and used as received.
Drugs were dissolved in sterile saline (0.9%).
Statistics
Results are average values ± SEM. Mainly unpaired
Student’s t-tests and 2-way analysis of variance (ANOVA)
with post-hoc Bonferroni tests were used to determine
statistical significance. Morphine withdrawal scores, pre-
withdrawal weight, and fecal boli weight were compared
using a 3-way ANOVA with a post-hoc Tukey’s Honestly
Significant Difference (HSD) Test. Linear regression analy-
sis was used to examine the relationship between stimula-
tion intensity and [NE]max. Differences were considered
significant when *Po0.05, **Po0.01, ***Po0.0001.
RESULTS
L Rats had Greater NE Tissue Content
Owing to the phenotypes discussed above, we investigated
the catecholamine tissue content in the nucleus accumbens
(NAc) and the vBNST in L rats compared with SD rats.
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We did not see significant differences between the strains in
the levels of DA in the NAc (SD: 5.25±0.96 mg/g n¼ 5,
L: 6.06±0.32 mg/g n¼ 5); however, in the vBNST, L rats had
significantly more DA and NE tissue content (SD NE:
4.55±0.84 mg/g n¼ 5 vs L NE: 10.9±1.52 mg/g n¼ 5; SD DA:
1.06±0.32 vs 3.15±0.46 n¼ 5; Figure 1 a–c). We presumed
the DA in the vBNST was mainly localized in NE neurons
because DA is the metabolic precursor to NE, and
dopaminergic projections are mainly to the dorsal lateral
BNST (Park et al, 2012; Meloni et al, 2006).
L Rats had Altered Noradrenergic Neurotransmission
Compared with SD Rats
Next, we examined regulation of noradrenergic synaptic
function using electrically-evoked release measured with
fast-scan cyclic voltammetry in anesthetized rats. This
method has been used extensively to characterize regulation
of DA and serotonin neurotransmission (John et al, 2006),
and we recently demonstrated its use to measure NE
dynamics in vivo in the vBNST (Herr et al, 2012; Park et al,
2009). With the carbon-fiber microelectrode positioned
directly beneath the anterior commissure, NE release was
evoked by electrical stimulation of the VNAB (example
electrode placement shown in Figure 1d). NE release (shown
in color plots encoding voltammetric recordings over a 15-s
interval) occurred upon stimulation, and its concentration
fell to its original value after stimulation. Consistent with
our previous report (Park et al, 2009), NE evoked release
was unaffected by raclopride (2 mg/kg), a D2 receptor
antagonist. In contrast, idazoxan (5 mg/kg, IDA), an a2–AR
antagonist, increased NE evoked release (examples in
Figure 1f).
We compared stimulated release of NE in the vBNST in
L and SD rats. The maximal amplitude of stimulated release
([NE]max) was evaluated as a function of pulse number in
the stimulus train (at 60 Hz) and fit with a linear regression.
Both strains responded to stimulation linearly, although
the slope of the line was greater in the L rats (L vs SD,
respectively, r2¼ 0.98 vs 0.99, slope: 4.93±0.11 vs
3.11±0.21, Po0.05; Figure 2b). The clearance half-life
(t1/2 or time from the [NE]max to half the maximal
concentration) following 60 Hz 60 pulse stimulations was
significantly greater in L rats than in SD rats (2.6±0.2 s,
n¼ 6 vs 1.9±0.1 s, n¼ 11 respectively, Po0.05; Figure 2c).
Additionally, when a saturating dose of the a2-AR
antagonist IDA (5 mg/kg i.p.; see Figure 3 for dose response
curve) was administered under the same stimulation
conditions to L rats, the increase in [NE]max was
significantly reduced compared with SD rats (163±11% of
pre-drug baseline, n¼ 8 vs 217±14% of pre-drug baseline
n¼ 10, respectively, Po0.05; Figure 3c), further suggesting
that NE dynamics are different in these strains. Autoradio-
graphy for a2-AR and the norepinephrine transporter
(NET), however, showed no differences between the strains
(SD n¼ 4, L n¼ 4, Supplementary Figure 1),suggesting total
protein levels are the same.
Following this characterization, we probed the effect of an
acute morphine injection (5 mg/kg i.p.) on NE dynamics.
Surprisingly, the acute morphine slightly but significantly
increased [NE]max in L rats but not in SD rats (116±9% of
pre-drug baseline, n¼ 5, Po0.05 vs 91±5% of pre-drug
baseline, n¼ 5; Figure 3e). There was no change in t1/2 in
either strain following acute morphine (L rats: 118±15% of
pre-drug baseline, n¼ 5; SD rats: 120±12% of pre-drug
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Figure 1 Fast-Scan Cyclic Voltammetry of norepinephrine (NE) in the bed nucleus of the stria terminalis (BNST). (a–c) Tissue content analysis of
catecholamines in the BNST and nucleus accumbens (NAc). (d) Representative histology of recording electrode placement in the ventral BNST (vBNST)
(black dashed circle) and area excised for tissue content analysis (red dashed line; LV, lateral ventricle; AC, anterior commissure). (e) Representative cyclic
voltammogram of NE at [NE]max. (f) Representative color plots demonstrating NE release and uptake in baseline conditions, following 2 mg/kg raclopride, or
5 mg/kg idazoxan.
Norepinephrine dynamics in the BNST
ZA McElligott et al
1667
Neuropsychopharmacology
to IDA was compared in acutely treated and non-
manipulated animals, there was a main effect of strain
(2-way ANOVA, F¼ 9.41, Po0.01; SD rats: 191±12.8% vs
217±14% of pre-drug baseline, n¼ 5 and 10,with and
without morphine, respectively; L rats: 158.6±5.4% vs
163±11% of pre-drug baseline, n¼ 5 and 8, with and
without morphine, respectively ) but not of drug treatment.
Therefore, acute morphine alone did not alter IDA response
in either strain.
Morphine-Dependent SD Rats had Increased
Anxiety-like Behavior
Next, we assayed animals that had experienced morphine
withdrawal using a dependence paradigm that modeled the
negative affect experienced by human addicts (Amitai et al,
2006; Koob, 2009; Schulteis et al, 1999). Once daily, we
administered 10 mg/kg morphine s.c., followed by 1 mg/kg
naloxone s.c. 4 h later (denoted MN), for a total of 3 days
(SD n¼ 27, L n¼ 22). Control animals received a saline
injection s.c. followed by 1 mg/kg naloxone 4 h later
(denoted SN) once daily for a total of 3 days (SD n¼ 26,
L n¼ 23). For 10 min following the injection of naloxone,
animals were assayed for withdrawal behaviors
(Supplementary Methods) and assigned a global withdrawal
score (Figure 4a). There was a significant effect of drug and
day on the global withdrawal score, but not of strain (3-way
ANOVA, F¼ 25.34, Po0.0001; Figure 4b). Thus, SD and L
rats that received morphine had significantly greater
withdrawal symptoms than their saline control counter-
parts. By the third day, both strains that received morphine
showed withdrawal scores that were significantly different
from the first day, while saline controls did not (Tukey’s
HSD Test, Po0.0001). Furthermore, there was an effect of
day and treatment, but not strain, with regard to pre-
withdrawal body weight (F¼ 15.99, Po0.001). Both strains
that received morphine had significant decreases in pre-
withdrawal body weight (day 3 vs day 1, Tukey’s HSD Test,
Po0.01 SD, Po0.05 L; Figure 4c). As a quantitative measure
of withdrawal-induced gut motility, we weighed the fecal
boli produced during the 60 min following naloxone
administration. Again, we found a significant effect of
treatment but not strain (F¼ 59.08, Po0.0001) and a
significant increase in day 3 vs day 1 fecal boli weight
(Tukey’s HSD Test, Po0.001 SD, Po0.01 L; Figure 4d). The
similarity in responses to the morphine/naloxone challenge
shows that morphine dependence was induced in both
strains. Owing to the short half-lives of morphine and
naloxone (Trescot et al, 2008), both drugs were eliminated
by experimentation time on day 4.
We next examined MN and SN animals of both strains on
the EPM. Both center and enclosed arm time showed an
interaction (2-way ANOVA, center: F¼ 5.78, Po0.05;
enclosed: F¼ 5.49, Po0.05) and a main effect of strain
(2-way ANOVA, center: F¼ 15.2, Po0.001; enclosed:
F¼ 14.0, Po0.001). Post-hoc analysis revealed significant
differences between SD-MN and SD-SN time spent in the
center (62±11 s vs 106±6 s, n¼ 8 and 7, respectively,
Po0.01) and the enclosed arms (222±15 s vs 175±9 s
respectively, Po0.05). L-MN rats, however, failed to show
any differences in time spent in the center or enclosed arms
when compared with L-SN rats (center: 47±12 s vs 44±8 s,
enclosed: 239±13 s vs 250±11 s, respectively, n¼ 8;
Figure 4 e–g). No significant differences were noted in
number of entries or open arm time between groups.
NE Dynamics were Altered in Morphine-Dependent SD
Rats but not L Rats
After establishing morphine dependence, animals were
anesthetized on day 4 and NE overflow was measured in
the vBNST using fast-scan cyclic voltammetry. We found
that the t1/2 in SD-MN rats was significantly longer than in
SD-SN rats (2.6±0.4 s vs 1.6±0.2 s, n¼ 5 and 6, respec-
tively, Po0.05; Figure 5a). Additionally the increase in
[NE]max, following IDA was significantly blunted in the
SD-MN rats as compared with SD-SN rats(147±9% vs
186±8%, n¼ 5 and 6, respectively, Po0.05; Figure 5b).
Interestingly, neither t1/2 nor the response to IDA was
altered by morphine dependence in the L rats (t1/2: L-MN
2.3±0.3 s vs L-SN 2.6±0.3 s, IDA: L-MN 163±25% of
Figure 2 Comparison of norepinephrine (NE) dynamics in naı̈ve Lewis
(L) and Sprague-Dawley (SD) rats. (a) Representative concentration traces
demonstrating NE release and uptake in the ventral bed nucleus of the stria
terminalis (vBNST) of both SD and L rats (scale bar, 100 nM; gray box
¼ stimulation, 60 pulses, 60 Hz). (b) Input–output curve of [NE]max at 20,
40, 60, 80, 100 and 120 pulses in SD and L rats. (c) Histogram of mean
clearance half-life of NE following 60 Hz, 60 pulse stimulation in both SD
and L rats.
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pre-drug baseline vs L-SN 157±10% of pre-drug baseline,
n¼ 5; Figure 5c and d). Neither SD-MN, L-MN, nor L-SN
groups were significantly different from the non-manipu-
lated L group with respect to either t1/2 or response to the
IDA challenge. Similar to non-manipulated animals, we did
not observe changes in a2-AR or NET binding in the vBNST
of either strain or condition (SD-MN n¼ 5, SD-SN n¼ 5,
L-MN n¼ 4, L-SN n¼ 5, Supplementary Figure 1).
Catecholamine Tissue Content in Morphine-Dependent
and Control Rats
Finally, we compared the catecholamine tissue content in
the BNST and NAc of MN animals and their controls
(Table 1). Contrary to naı̈ve animals, when NE tissue
content was examined there was no significant interaction
between MN and SN animals of each strain (2-way ANOVA,
SD-MN: 1.97±0.49 mg/g, n¼ 9; SD-SN 3.23±0.72 mg/g,
n¼ 8; L-MN: 4.36±0.70 mg/g, n¼ 5; L-SN: 3.12±0.65 mg/g,
n¼ 5 P40.05). When BNST DA levels were examined,
however, there was a main effect of both strain and drug
treatment (2-way ANOVA, SD-MN: 1.32±0.22 mg/g, n¼ 9;
SD-SN 0.71±0.17 mg/g n¼ 8; L-MN: 2.69±1.02 mg/g, n¼ 5;
L-SN: 1.55±0.59 mg/g, n¼ 5, Po0.05 for each factor).
Interestingly, when DA levels in the NAc were measured,
there was a significant interaction (2-way ANOVA, SD-MN:
5.21±0.91 mg/g, n¼ 9; SD-SN 4.85±0.75 mg/g n¼ 8; L-MN:
7.25±1.31 mg/g, n¼ 5; L-SN: 2.37þ 0.46 mg/g, n¼ 5
Po0.05). Post-hoc analysis revealed that L-MN rats had
significantly higher DA in the NAc than their L-SN controls
(Po0.05), whereas SD animals showed no difference.
DISCUSSION
Previous studies have shown that L rats have anxiety and
PTSD-like phenotypes (Cohen et al, 2006) and elevated
extracellular NE in the BNST in response to a stressor
(Pardon et al, 2002). They are also predisposed to substance
abuse (Picetti et al, 2012; Sanchez-Cardoso et al, 2007).
Here, we found that the tissue content of NE and DA in the
vBNST, but not DA in the NAc, was elevated in L rats as
compared with SD rats. Furthermore, using fast-scan cyclic
voltammetry, we uncovered profound differences in the
regulation of NE synaptic function in the vBNST in the two
strains. NE is less regulated in L rats when compared with
SD rats because they have a reduced NE uptake rate and less
sensitivity to an a2-AR antagonist. When SD rats were made
Figure 3 Effect of idazoxan (IDA) and morphine on norepinephrine release in the ventral bed nucleus of the stria terminalis (vBNST).
(a and b) Representative concentration traces of Sprague-Dawley (SD) and Lewis (L) rats, respectively. Solid line—evoked norepinephrine (NE)
concentration with 60 Hz, 60 pulses stimulation; dashed line—evoked NE concentration following 5 mg/kg IDA with the same electrical stimulus. (c) Average
[NE]max following 5 mg/kg IDA relative to pre-drug stimulated release. (d) Change in [NE]max as percent of pre-drug baseline in both Sprague-Dawley
(closed squares) and Lewis (open circles) rats, plotted vs log concentration of IDA (n¼ 3 each strain). (e) Average [NE]max to acute 5 mg/kg morphine
relative to pre-drug stimulated release. (f) Average clearance half-life following acute 5 mg/kg morphine relative to pre-drug stimulated release.
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dependent on morphine the two key regulators of NE
overflow, uptake, and autoreceptor regulation, were both
reduced such that NE neurotransmission resembled that of
a non-manipulated L rat. In L rats, however, NE clearance
and autoreceptor regulation were unaffected by morphine
dependence. This physiological phenomenon correlated to
an increase in anxiety-like behavior in SD-MN rats but not
L-MN rats, as compared with their controls. The results
demonstrate a robust plasticity within an organism’s
noradrenergic system that may be influenced by genetic
factors as well as environmental insults.
L Rats Exhibited Poor Control Over NE Release and
Clearance
Neurotransmitter levels in the extracellular space are
determined by the balance between release and uptake
(Wightman et al, 1988). Release is a function of the rate of
impulse flow (action potentials), the relative amount of NE
in the releasable pool, and regulation by autoreceptors. The
principal inhibitory autoreceptor in noradrenergic neurons
is the a2 -AR (Trendelenburg et al, 2001). NET is primarily
responsible for NE clearance by uptake (Xu et al, 2000), and
it follows Michaelis–Menten kinetics (Park et al, 2009).
Electrical stimulation of NE neurons provides a convenient
way to monitor release and uptake. Stimulation at
supraphysiological frequencies allows release to predomi-
nate over uptake, enabling its nature to be examined. The
maximum concentration achieved ([NE]max), measured at
the end of the stimulation, is thus predominantly a function
of release. Recently the Jones lab has shown that the t1/2
after the stimulation provides a measure of the rate of
uptake that agrees with more complex Michaelis–Menten
modeling (Yorgason et al, 2011). Thus, the electrical
stimulations used here allowed quantification of several
basic parameters that control extracellular NE.
Our studies showed that [NE]max is similar in the two
strains with shorter stimulation trains. This is surprising
because the vBNST NE content is twice as large in naı̈ve L
rats compared with SD rats. While release is linear in both
strains, the slope of the regression line in the SD rats was
significantly less than L rats, indicating that L rats have a
larger releasable pool (Montague et al, 2004). Microdialysis
studies have shown that extracellular NE increases during
restraint stress in L rats relative to SD rats (Pardon et al,
2002), possibly arising from the larger releasable pool
Figure 4 Morphine dependence in Sprague-Dawley (SD) and Lewis (L) rats. (a) Model of drug administration paradigm. (b) Global withdrawal scores,
(c) pre-withdrawal body weight (as % of day 1), and (d) fecal boli weight in SD morphine/naloxone (SD-MN) and L-MN rats following withdrawal,
compared with control SD saline/naloxone (SD-SN) and L-SN rats. Time spent in (e) open arms (f), center or (g) closed arms of the elevated plus maze as a
fraction of total time in the maze in SD-MN, SD-SN, L-MN, and L-SN rats.
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revealed in this work. Additionally, our experiments that
probed the efficacy of the autoreceptor revealed that it
exerts greater inhibition of release in SD rats. Although
urethane anesthesia has been shown to stimulate a2-ARs in
the periphery (Armstrong et al, 1982), our results in
anesthetized animals mimicked the IDA effects observed
in awake rats (Park et al, 2012). Taken together, our results
suggest that L rats appear optimized for maximal NE
neurotransmission. The combination of high content, low
uptake rate, and low autoreceptor regulation ensures
enhanced NE tone.
NE signaling in the BNST has been implicated in
mediating control over the HPA axis and in anxiety-like
behavior (Cecchi et al, 2002) and can release CRF within the
BNST (McElligott et al, 2010; Nobis et al, 2011). Further-
more, prolonged NE signaling in the BNST induces synaptic
plasticity that is modulated by stress (McElligott et al, 2010;
McElligott and Winder, 2008). The altered mechanisms in
L rats that allow enhanced NE signaling may result in their
anxiety-like phenotypes observed by others (Cohen et al,
2006), and could translate to anxiety-susceptible human
populations. Indeed, recent data show that targeting
noradrenergic signaling mechanisms may alleviate symp-
toms of substance abuse and PTSD (Raskind et al, 2000;
Simpson et al, 2008).
Morphine Dependence Enhanced Anxiety-Like
Behavior, Increased NE Clearance Half-Life and
Reduced Autoreceptor Function in SD but not L Rats
It is hypothesized in the allostasis model that the
progression to addiction requires the engagement of
neuronal stress/anxiety systems, including the release of
NE in the BNST (Delfs et al, 2000; Koob, 2009). Therefore, a
predisposition to the negative emotional state associated
with engagement of these neuronal substrates might explain
the co-morbidity that is associated with anxiety disorders
and addiction. L rats have a high anxiety/PTSD phenotype
that is at least partially due to BNST function (Cohen et al,
2006; Duvarci et al, 2009) and a propensity to self-
administer and escalate opiate intake (Picetti et al, 2012;
Sanchez-Cardoso et al, 2007). Interestingly, following with-
drawal from morphine, but not acute morphine, SD rats
showed profound plasticity in both autoreceptor regulation
and uptake rates, as well as enhanced anxiety-like behavior.
Moreover, the SD-MN rats had uptake rates and auto-
receptor profiles indistinguishable from non-manipulated
L rats. Surprisingly, L-MN rats exhibited neither this plasticity
nor further increases in anxiety-like behavior, suggesting
that autoreceptors and uptake rates in the L rats may be in a
maximally depressed state. The correlation between vBNST
NE and increased anxiety revealed in this work implicate
plasticity at noradrenergic synapses as one mechanism for
the development of anxiety and addiction phenotypes.
Figure 5 Clearance half-life and change in response following idazoxan (IDA) administration in morphine/naloxone (MN) animals vs saline controls.
(a) t1/2 and (b) change in [NE]max as percent of pre-drug baseline in MN Sprague-Dawley (SD) rats vs saline controls (Po0.05). (c) t1/2 and (d) change in
[NE]max as percent of pre-drug baseline in MN Lewis (L) rats vs saline controls (n.s.). SN, saline/naloxone.
Table 1 Catecholamine Tissue Content Analysis (mg/g) in the
Nucleus Accumbens and Ventral Bed Nucleus of the Stria
Terminalis of Control (Saline/Naloxone) and Morphine-Dependent








Saline/naloxone (n¼ 8) 4.85±0.75 3.23±0.72 0.71±0.17
Morphine/naloxone (n¼ 9) 5.21±0.91 1.97±0.49 1.32±0.22
Lewis
Saline/naloxone (n¼ 5) 2.37±0.46* 3.12±0.65 1.23±0.37
Morphine/naloxone (n¼ 5) 7.25±1.31* 4.36±0.70 2.69±1.02
*Po0.05.
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Interestingly, our autoradiography experiments demon-
strated that neither naı̈ve, MN, nor SN rats of either strain
showed alterations in a2-AR or NET levels in the vBNST.
This may be due to several reasons. First, this technique
probes targets that are on the cell surface and in internal
pools; therefore, it does not exclusively examine functional
receptors and transporters. Second, it is possible that the
functional changes we observed are not due to alterations in
protein level, but due to a post-translational modification.
Finally, the BNST has strong expression of nonspecific
organic cation transporters, which also may have a role in
the clearance of NE (Gasser et al, 2009) and could be
manipulated by the gene–environment interactions we
probed here. Nevertheless, the functional results clearly
showed that the synaptic dynamics are dramatically
different between SD and L rats, and that they were greatly
altered in SD-MN rats.
Examining catecholamine tissue content in MN and control
rats showed interesting changes in our treatment groups. Our
data demonstrated that naloxone treatment lowered NE levels
in the BNST in both strains regardless of pretreatment with
morphine, and the effect was long lasting. These data are
intriguing because naloxone and other m-opioid antagonists
are prescribed to humans for opiate and alcohol dependence
(Heilig and Egli, 2006). Further, we found that L-MN rats had
elevated DA in their NAc as compared with their controls,
which may also contribute to their self-administration
escalation phenotype (Picetti et al, 2012).
We have shown that NE synapses in a genetic model of
anxiety and addiction (L rats) permit exacerbated nora-
drenergic signaling due to reduced uptake and autoreceptor
function. Furthermore, we showed that vBNST NE synapses
in a relatively non-anxious SD rat resemble L rat NE
synapses when SD rats are made morphine dependent.
These data suggest that noradrenergic synapses undergo a
plasticity event where increased NE signaling (here stem-
ming from precipitated withdrawal) results in a biophysical/
biochemical change within the presynaptic cell to permit
prolongation of future NE signaling on post synaptic cells.
Furthermore, these alterations correlated to enhanced
anxiety-like behavior in the SD rats. Additionally, the data
support the allostasis model (Koob and Volkow, 2010) and
the idea that genetic factors contributing to negative affect
could in turn increase susceptibility to developing sub-
stance abuse issues.
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